Dr Emily Rebecca Shank, DO | |
12680 Olive Blvd Ste 300, Saint Louis, MO 63141-6322 | |
(314) 251-8888 | |
(314) 251-8889 |
Full Name | Dr Emily Rebecca Shank |
---|---|
Gender | Female |
Speciality | Family Medicine |
Location | 12680 Olive Blvd Ste 300, Saint Louis, Missouri |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235876863 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 2022021160 (Missouri) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Emily Rebecca Shank, DO 12680 Olive Blvd Ste 300, Saint Louis, MO 63141-6322 Ph: (314) 251-8888 | Dr Emily Rebecca Shank, DO 12680 Olive Blvd Ste 300, Saint Louis, MO 63141-6322 Ph: (314) 251-8888 |
News Archive
TeleTracking Technologies and Sodexo, Inc. today announced a multi-year renewal of their long-standing sales partnership to bring automated patient flow and transport solutions to hospitals.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT drug delivery technology and internal pipeline through out-licensing partnerships, today announced that the Moores Cancer Center at the University of California San Diego (UCSD) has filed an Investigational New Drug Application with the U.S. Food & Drug Administration ("FDA") for approval to test Nupen, Apricus Bio's proprietary, topical NexACT-based formulation of filgrastim (Neupogen).
New drugstore Ratings published in the May issue of Consumer Reports and available online at www.ConsumerReportsHealth.org reveal that the overwhelming majority (94%) of readers are highly satisfied with their experiences at neighborhood independent drugstores. While customers said they were generally satisfied with their pharmacies, some were irked by long waits and lagging service at some big box stores.
Ocera Therapeutics Inc., a privately-held biopharmaceutical company focused on the development and commercialization of proprietary agents to treat gastrointestinal and liver diseases, announced today that it has received a CE Mark for Zysa (spherical carbon adsorbent, formerly AST-120) for the treatment of diarrhea predominant IBS (IBS-d), a condition affecting 10-15% of the Western world.
› Verified 8 days ago
Mrs. Jetuan L Rowley-herron, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 5471 Dr Martin Luther King Dr, Saint Louis, MO 63112 Phone: 314-367-5820 Fax: 314-367-7010 | |
Amy Elizabeth Roberts, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8888 Ladue Rd Ste 210, Saint Louis, MO 63124 Phone: 314-996-5900 Fax: 314-995-5910 | |
Christopher Brian Espana, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5034 Griffin Rd, Saint Louis, MO 63128 Phone: 314-843-7333 Fax: 314-843-9946 | |
Mrs. Teresita Agustin Cometa, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 5471 Dr Martin Luther King Dr, Saint Louis, MO 63112 Phone: 314-367-5820 Fax: 314-367-6326 | |
Dr. Michael T Railey, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6125 Clayton Ave, Ste 222, Saint Louis, MO 63139 Phone: 314-768-3685 Fax: 314-768-3940 | |
Dr. Alan Valente A Padua, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13303 Tesson Ferry Rd Ste 100, Saint Louis, MO 63128 Phone: 314-722-4741 Fax: 314-722-4731 | |
Anne Usha Jacob, M.B.B.S. Family Medicine Medicare: Medicare Enrolled Practice Location: 3649 Page Blvd, Saint Louis, MO 63113 Phone: 314-288-0071 Fax: 314-758-5210 |